Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Tetrylammonium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.80 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.80 |
| ▸ | KCNA1 | Q09470 | 1/20 | 0.80 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.73 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.73 |
| ▸ | ATM | Q13315 | 1/20 | 0.73 |
| ▸ | DNM1 | Q05193 | 4/20 | 0.37 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrylammonium SCHEMBL28600427 | 1.00 | TSHR (0.80) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL1419554 | 1.00 | TSHR (0.80) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL9292825 | 1.00 | TSHR (0.80) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL28600737 | 0.95 | TSHR (0.89) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL28768609 | 0.95 | TSHR (0.89) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL3722218 | 0.95 | TSHR (0.89) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL1035999 | 0.95 | TSHR (0.89) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL7740433 | 0.95 | TSHR (0.89) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL10887 | 0.95 | TSHR (0.89) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL5142182 | 0.95 | TSHR (0.89) | TSHRNFKB1KCNA1KDM4EPMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 332 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240317794-A1 | 3'-OH RNA-CONTAINING OLIGONUCLEOTIDE DEPROTECTION | BANK OF AMERICA, N.A. | 2024-09-26 | — | — | US | claimed |
| CN-117039207-B | Battery, iodine electrode material and preparation method of electrolyte | 广东工业大学 | 2024-07-30 | — | — | CN | claimed |
| CN-117039207-A | Battery, iodine electrode material and preparation method of electrolyte | 广东工业大学 | 2023-11-10 | — | — | CN | claimed |
| CN-109641930-B | Preparation method of 2-fluoro-2-methyl deoxynucleoside serving as sofosbuvir intermediate | 正大天晴药业集团股份有限公司 | 2020-12-04 | — | — | CN | claimed |
| US-8916429-B2 | Aqueous cleaning techniques and compositions for use in semiconductor device manufacturing | TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) | 2014-12-23 | — | — | US | claimed |
| US-20130288436-A1 | Aqueous Cleaning Techniques and Compositions for use in Semiconductor Device Manufacturing | TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) | 2013-10-31 | — | — | US | claimed |
| EP-0165253-B1 | FABRICATION OF HIGH-SILICA GLASS ARTICLE | AT&T Corp. (US) | 1989-01-11 | — | — | EP | claimed |
| US-4707174-A | OPTICAL FIBERS, DRYING, CHLORINE, SINTERING, FLUORINE, BUBBLE-FREE | AMERICAN TELEPHONE AND TELEGRAPH COMPANY, AT&T BELL LABORATORIES (US) | 1987-11-17 | — | — | US | claimed |
| EP-0165253-A1 | FABRICATION OF HIGH-SILICA GLASS ARTICLE. | AMERICAN TELEPHONE & TELEGRAPH (US) | 1985-12-27 | — | — | EP | claimed |
| WO-1985002837-A1 | FABRICATION OF HIGH-SILICA GLASS ARTICLE | AMERICAN TELEPHONE & TELEGRAPH COMPANY (US) | 1985-07-04 | — | — | WO | claimed |
| EP-0147029-A1 | Fabrication of high-silica glass article | AT&T Corp. (US) | 1985-07-03 | — | — | EP | claimed |
| US-20260125272-A1 | ZEOLITIC MATERIALS AND METHODS OF MAKING AND USING THEREOF | OHIO STATE INNOVATION FOUNDATION (US) | 2026-05-07 | — | — | US | disclosed |
| EP-4676923-A1 | BIARYLAMIDE DERIVATIVES AND THEIR USE AS PKMYT1 INHIBITORS | Cancer Research Technology Limited (GB) | 2026-01-14 | — | — | EP | disclosed |
| US-12448378-B2 | Fluoropyrrolopyridine compound and application thereof | WUXI LIFE FOUNTAIN BIOTECH CO., LTD (CN) | 2025-10-21 | — | — | US | disclosed |
| US-20250289828-A1 | MEDIUM- OR MACRO-CYCLIC BENZYL-SUBSTITUTED HETEROCYCLE DERIVATIVES AND RELATED USES | CENTESSA PHARMACEUTICALS UK LTD (GB) | 2025-09-18 | — | — | US | disclosed |
| US-4707174-A | OPTICAL FIBERS, DRYING, CHLORINE, SINTERING, FLUORINE, BUBBLE-FREE | AMERICAN TELEPHONE AND TELEGRAPH COMPANY, AT&T BELL LABORATORIES (US) | 1987-11-17 | — | — | US | disclosed |
| EP-0215603-A1 | Fabrication of high-silica glass article | AT&T Corp. (US) | 1987-03-25 | — | — | EP | disclosed |
| EP-0165253-A1 | FABRICATION OF HIGH-SILICA GLASS ARTICLE. | AMERICAN TELEPHONE & TELEGRAPH (US) | 1985-12-27 | — | — | EP | disclosed |
| WO-1985002837-A1 | FABRICATION OF HIGH-SILICA GLASS ARTICLE | AMERICAN TELEPHONE & TELEGRAPH COMPANY (US) | 1985-07-04 | — | — | WO | disclosed |
| EP-0147029-A1 | Fabrication of high-silica glass article | AT&T Corp. (US) | 1985-07-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125272-A1 | ZEOLITIC MATERIALS AND METHODS OF MAKING AND USING THEREOF | MIF, CA1, CLK1 | TSHR 1020/4885NFKB1 3934/4885KCNA1 2981/4885 |
| US-20250289828-A1 | MEDIUM- OR MACRO-CYCLIC BENZYL-SUBSTITUTED HETEROCYCLE DERIVATIVES AND RELATED USES | HCRTR2, HCRTR1, CRHR2 | TSHR 355/4885NFKB1 3281/4885KCNA1 811/4885 |
| US-20240317794-A1 | 3'-OH RNA-CONTAINING OLIGONUCLEOTIDE DEPROTECTION | NSUN2, NSUN3, RNGTT | TSHR 3857/4885NFKB1 3149/4885KCNA1 4858/4885 |
| US-12448378-B2 | Fluoropyrrolopyridine compound and application thereof | QDPR, DPYD, KCNJ2 | TSHR 3522/4885NFKB1 3681/4885KCNA1 71/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.